Targeted NIF-hirulog hybrid (Shandong New Time Pharmaceutical)
重组白细胞抑制因子和水蛭肽嵌合蛋白（山东新时代药业）
Report date: 2025/02/27 16:29:40
Base Information
Drug NameTargeted NIF-hirulog hybrid (Shandong New Time Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong New Time Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A